How has been the historical performance of Rossari Biotech?

Answer:The historical performance of Rossari Biotech shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Rossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025, reflecting a robust growth trend. Total operating income has followed a similar pattern, rising from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025. The company's operating profit (PBDIT) has also shown a positive trend, growing from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025. Profit before tax has increased from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, while profit after tax rose from INR 65.47 crore to INR 135.40 crore in the same period. The company's total assets have expanded from INR 471.46 crore in March 2020 to INR 1,885.67 crore in March 2025, indicating strong asset growth. Total liabilities have also increased, from INR 471.46 crore to INR 1,885.67 crore, with total debt rising from INR 61.01 crore to INR 187.97 crore. Cash flow from operating activities has improved significantly, from INR 56 crore in March 2020 to INR 137 crore in March 2025, contributing to a net cash inflow of INR 19 crore in March 2025. Overall, Rossari Biotech has demonstrated substantial growth in revenue, profitability, and asset base over the years.